Popular terms

[SEARCH]

Indole topics
Indole Derivatives
Tryptophan
Pharmaceutically Acceptable Salt
Protease Inhibitors
Antivirals
Antiinfective
Pharmaceutical Formulations
Protease Inhibitor
Pharmaceutical Formulation
Immunomodulator
Entry Inhibitors
Piperazine
Cycloalkyl
Alkyl Group
Carbon Atoms

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Indole patents



      
           
This page is updated frequently with new Indole-related patent applications. Subscribe to the Indole RSS feed to automatically get the update: related Indole RSS feeds. RSS updates for this page: Indole RSS RSS



Date/App# patent app List of recent Indole-related patents
08/20/15
20150236272 
 Novel compound and organic electroluminescence device including thesame patent thumbnailNovel compound and organic electroluminescence device including thesame
The present invention relates to a novel indole-based compound having excellent hole injection and transport capabilities, light-emitting capabilities, and the like, and an organic electroluminescence device which includes the indole-based compound in one or more organic material layers thereof so as to improve characteristics such as light-emitting efficiency, driving voltage, and lifespan.. .
Doosan Corporation


08/20/15
20150231119 
 Azaindoles as respiratory syncytial virus antiviral agents patent thumbnailAzaindoles as respiratory syncytial virus antiviral agents
Compositions containing these compounds as active ingredient and processes for preparing these compounds and compositions.. .

08/13/15
20150225405 
 Substituted-1,4-dihydropyrazolo[4,3-b]indoles patent thumbnailSubstituted-1,4-dihydropyrazolo[4,3-b]indoles
And pharmaceutically acceptable salts thereof, wherein l, r1, r2, r3, r4, r5, r6, and r7 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of formula 1, to pharmaceutical compositions which contain them, and to their use for treating obesity and related diseases, disorders, and conditions associated with metap2..

08/06/15
20150218146 
 Substituted oxindole derivatives, medicaments containing said derivatives and use thereof patent thumbnailSubstituted oxindole derivatives, medicaments containing said derivatives and use thereof
The invention relates to novel oxindole derivatives of general formula (i), wherein the substituents r1, r2, a, b, and y are defined as in claim 1. The invention further relates to medicaments containing said derivatives, and use thereof for the prevention and/or treatment of vasopressin-dependent diseases..
Abbvie Deutschland Gmbh & Co. Kg


08/06/15
20150218133 
 6-aminoindole derivatives as trp channel antagonists patent thumbnail6-aminoindole derivatives as trp channel antagonists
And pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of manufacturing and using the compounds of formula (i) as well as pharmaceutical compositions containing such compounds.

08/06/15
20150218122 
 Process of producing cycloalkylcarboxamido-indole compounds patent thumbnailProcess of producing cycloalkylcarboxamido-indole compounds
The present invention features processes for preparing compounds, such as (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl)cyclopropanecarboxamide (compound 1), useful for treating cftr mediated diseases such as cystic fibrosis.. .
Vertex Pharmaceuticals Incorporated


08/06/15
20150218095 
 Icmt inhibitors patent thumbnailIcmt inhibitors
The invention provides a 1,3,5-substituted indole wherein the substituent at position 1 is a c6 to c12 alkyl group; the substituent at position 3 is ch2nr1r2 wherein r1 is h or c1 to c3 alkyl, r1 being optionally substituted with —oh, —sh, —nh2 or nhalkyl, wherein alkyl is a c1 to c4 alkyl group, and r2 is c1 to c3 alkyl or (ch2)n bonded to position 2 of the indole, wherein n is 1, 2 or 3; and the substituent at position 5 is either an optionally substituted nitrogen containing heteroaromatic ring or an aminosulfonylphenyl group or an alkylsulfonylphenyl group.. .
National University Of Singapore


08/06/15
20150216845 
 Ipa as a therapeutic agent, as a protective agent, and as a biomarker of disease risk patent thumbnailIpa as a therapeutic agent, as a protective agent, and as a biomarker of disease risk
indole-3-propionic acid as a marker and for treatment for huntington disease.. .
Counterpoint Health Solutions, Inc.


08/06/15
20150216794 
 Methods of treating pain associated with osteoarthritis of a joint with a topical formulation of a spiro-oxindole compound patent thumbnailMethods of treating pain associated with osteoarthritis of a joint with a topical formulation of a spiro-oxindole compound
Are disclosed. The methods provide excellent penetration of the spiro-oxindole compound into the synovial membrane of the affected joint to effectively reduce the severity of the pain and/or to alleviate the pain with minimal or negligible systemic exposure..

08/06/15
20150216175 
 Azaindole carboxylic acid amides and azaindole thiocarboxylic acid amides for use as insecticides and acaricides patent thumbnailAzaindole carboxylic acid amides and azaindole thiocarboxylic acid amides for use as insecticides and acaricides
In which r1 to r6, a, y, x, q1, q2, n and m are each as defined in the description and to a process for their preparation and to their use as insecticides and acaricides.. .

07/30/15
20150214494 

Organic electroluminescent materials and devices


A luminescent compound that is a metal complex with ligands containing pyrrole or indole in the structure, where the pyrrole or inidole has an aromatic substitutent that has at least one ortho substitution is disclosed.. .
Universal Display Corporation


07/30/15
20150214490 

Organic light-emitting compound and organic electroluminescent device using same


The present invention relates to a novel indole-based compound having excellent hole injection and transport capabilities, light-emission, and other properties, and to an organic electroluminescent device the luminous efficiency, driving voltage, service life, and other characteristics of which are improved due to containing the compound in one or more organic material layers.. .
Doosan Corporation


07/30/15
20150210707 

Crystals of dispiropyrrolidine derivatives


Crystals of a dispiropyrrolidine compound or a salt thereof which inhibits the action of mdm2 are provided. The present invention provides crystals of (3′r,4′s,5′r)-n-[(3r,6s)-6-carbamoyltetrahydro-2h-pyran-3-yl]-6″-chloro-4′-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2″-oxo-1″,2″-dihydrodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indole]-5′-carboxamide or a salt thereof which inhibits mdm2 and has anti-tumor activity.
Daiichi Sankyo Company, Limited


07/30/15
20150210700 

Indole-substituted pyrrolopyrimidinyl inhibitors of uba6


Disclosed are chemical entities that inhibit uba6, each of which is a compound of formula /: formula (i) or a pharmaceutically acceptable salt thereof, wherein r*1 is —h or —ch3; and y is formula (ii) or formula (iii), wherein r2 is —h, —ch3 or c1-4 alkyloxycarbonyl; and rs7.1, rs7.2 and rs8.1 are defined herein; pharmaceutical compositions comprising the chemical entities; and methods of using the chemical entities. These chemical entities are useful for treating disorders, particularly cell proliferation disorders, including cancers..
Millennium Pharmaceuticals, Inc.


07/30/15
20150210687 

N-alkylated indole and indazole compounds as rorgammat inhibitors and uses thereof


The present invention relates to compounds according to formula i and pharmaceutically acceptable salts or solvates thereof. Such compounds can be used in the treatment of rorgammat-mediated diseases or conditions..
Merck Sharp & Dohme Corp.


07/30/15
20150209348 

Histamine 4 receptor partial agonists, inverse agonists or antagonists for use in treating non-autoimmune uveitis


The invention provides a compound which is a histamine 4 receptor antagonist, partial agonist or inverse agonist, for use in the treatment of non-autoimmune uveitis. The compound preferably has a structural core comprising a substituted pyrimidine group, such as an aminopyrimidine, diaminopyrimidine or triaminopyrimidine group, a thienopyrimidine, a furopyrimidine, a benzimidazole, an aryl or heteroaryl-fused pyrimidine, an indole, a bicyclic heteroaryl-substituted imidazole or a quinazoline group..
Ucl Business Plc


07/23/15
20150203505 

Indole carboxamide derivative


The present inventors have conducted studies on mt1 and/or mt2 receptor agonists, and have found that an indole carboxamide compound has an mt1 and/or mt2 receptor agonistic action, thereby completing the present invention. The indole carboxamide compound of the present invention has the mt1 and/or mt2 receptor agonistic action as well as a low cns penetration, and therefore, it can be used as an agent for preventing and/or treating urological diseases; in one embodiment, lower urinary tract symptoms; in another embodiment, urine storage symptom, in another embodiment, urinary incontinence; in a still another embodiment, stress urinary incontinence; and the like..

07/23/15
20150203451 

Process for preparing substituted indole derivatives


The present invention relates to a process for preparing substituted indole derivatives. More particularly, the invention refers to a new method to synthesize indole-derivatives by oxidative c—h-functionalization..
Studiengesellschaft Kohle Mbh


07/23/15
20150203450 

Indole and azaindole derivative having ampk-activating activity


R4, r7 and r8 are each independently hydrogen, halogen, hydroxy, cyano, nitro, carboxy, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl, substituted or unsubstituted heterocyclyl, or the like.. .

07/09/15
20150191465 

Azaindole derivatives


And pharmaceutically acceptable salts thereof, wherein r1, r2, r3, r4, r5, r6, r7, r8, r9, and r10 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of formula 1, to pharmaceutical compositions which contain them, and to their use for treating immunological disorders, cardiovascular disease, cancer, and other diseases, disorders or conditions associated with pi3kδ..

07/09/15
20150191434 

3-cyclohexenyl and cyclohexyl substituted indole and indazole compounds as rorgammat inhibitors and uses thereof


The present invention relates to compounds according to formula i and pharmaceutically acceptable salts or solvates thereof. Such compounds can be used in the treatment of rorgammat-mediated diseases or conditions..
Merck Sharp & Dohme Corp.


07/09/15
20150190378 

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3- dioxygenase


The present invention is directed to 1,2,5-oxadiazole derivatives, and compositions of the same, which are inhibitors of indoleamine 2,3-dioxygenase and are useful in the treatment of cancer and other disorders, and to the processes and intermediates for making such 1,2,5-oxadiazole derivatives.. .
Incyte Corporation


07/02/15
20150183739 

Processes for the preparation of isoindole compounds and isotopologues thereof


Processes for the preparation of certain isoindole compounds, and isotopologues thereof, are provided. In some embodiments, the processes comprise catalytic assymetrical hydrogenation with hydrogen gas or deuterium gas in a solvent containing exchangeable proton or deuterium for proton-deuterium exchange..
Celgene Corporation


07/02/15
20150182509 

Tetracyclic compounds


This disclosure relates to new tetracyclic compounds that may be used to modulate a histamine receptor in an individual. The compounds in one embodiment are tetracyclic [4,3-b]indoles.
Medivation Technologies, Inc.


07/02/15
20150182502 

Composition for prevention or treatment of cancer comprising n-methylenenaphtho[2,1-b]furan-2-carbohydrazide derivatives as an active ingredient


The present invention relates to ethyl(2-methyl-3{(e)-[(naphtho[2,1-b]furan-2-ylcarbonyl)hydrazono]methyl}-1h-indole-1-yl)acetate, the novel mitosis inhibitor. The said ethyl(2-methyl-3{(e)-[(naphtho[2,1-b]furan-2-ylcarbonyl)hydrazono]methyl}-1h-indole-1-yl)acetate not only induces apoptosis by inhibiting tubulin polymerization in the course of mitosis but also displays an excellent anticancer effect in the multi-drug resistant cancer cells, so that it can be effectively used for the treatment of cell proliferative disease including various cancers..
Korea Research Institute Of Bioscience And Biotechnology


06/25/15
20150175539 

Indole carboxamide derivatives and uses thereof


Wherein r1, r2, r3, r4, r5 and r6 are as defined herein.. .

06/25/15
20150174101 

Melatonin tablet and methods of preparation and use


The present invention provides a pharmaceutical composition for sublingual or buccal administration of actives with low to poor aqueous solubility, e.g. The indole hormone melatonin, which contains a solution of the active in a pharmaceutically acceptable solvent adsorbed or absorbed onto particles of a pharmaceutically acceptable carrier and methods of preparing and using the pharmaceutical composition..
Pharmaceutical Productions, Inc.


06/18/15
20150168403 

Identifying antifungal agents that inhibit iaa or a yap family member


The present invention relates to methods of screening for antifungal agents by identifying agents that bind to or otherwise inhibit indole-3-acetic acid (iaa) or that bind to or otherwise inhibit the expression or activity of a protein within the yap family or a gene encoding a protein within the yap family.. .
Worcester Polytechnic Institute


06/18/15
20150165063 

1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment


The invention provides antibody-drug conjugates comprising an antibody conjugated to a 1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole (cbi) dimer drug moiety via a linker, and methods of using the antibody-drug conjugates.. .
Genentech, Inc.


06/18/15
20150164860 

Anticancer treatment methods involving analogs and derivatives of 3-(2-substituted-ethyl) indole compounds


Wherein r is defined herein.. .

06/11/15
20150158845 

5-halogen-substituted oxindole derivatives and use thereof for treating vasopressin-dependent diseases


The present invention relates to novel 5-halogen-substituted oxindole derivatives, pharmaceutical compositions comprising them, and their use for the treatment of vasopressin-dependent disorders.. .
Abbvie Deutschland Gmbh & Co. Kg


06/04/15
20150155496 

Compound having substituted anthracene ring structure and pyridoindole ring structure, and organic electroluminescent device


There is provided an organic compound having excellent characteristics, including excellent electron-injecting/transporting performance, hole blocking ability, and high stability in the thin-film state, for use as material of an organic electroluminescent device having high efficiency and high durability. There is also provided a high-efficient and high-durable organic electroluminescent device using the compound.
Hodogaya Chemical Co., Ltd.


06/04/15
20150152104 

7-azaindole derivatives


Compounds of the formula (i) in which r, r1, r2 and r3 have the meanings indicated in claim 1, are inhibitors of pdk1 and cell proliferation/cell vitality and can be employed for the treatment of tumours.. .
Merck Patent Gmbh


06/04/15
20150152103 

Azaindoles useful as inhibitors of jak and other protein kinases


The present invention relates to inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders..
Vertex Pharmaceuticals Incorporated


05/28/15
20150148292 

Bone morphogenetic protein pathway activation, compositions for ossification, and methods related thereto


The disclosure relates to compounds and compositions for bone formation, fracture treatment, bone grafting, bone fusion, cartilage maintenance and repair, and methods related thereto. In certain embodiments, the disclosure relates to compositions comprising one or more compound(s) disclosed herein, such as 2-(2-methoxybenzylidene)-1-indan-one; n-(4-arsonophenyl)glycine; 1,2-benzenedicarboxylic acid, 1-(1-methylheptyl)ester; (4′-hydroxybiphenyl-4-yl) (phenyl)methanone; 2,2-dimethylchroman-6-carboxylic acid, (4,7-dihydroxy-8-methyl-2-oxo-2h-chromen-3-yl)amide; ethyl 2-((4-chlorophenyl)thio)-1,3-benzothiazol-6-yl carbamate; ethyl (2-(azepan-1-yl)benzo[d]thiazol-6-yl) carbamate; porfiromycin; 1,3-benzodioxol-5-yl-[4-(3,4,5-trimethoxybenzoyl)-3-furyl]methanone; tricinolone acetophenonide; 2,4-bis(3,4-dimethoxyphenyl)-4h-pyrano[3,2-c]chromen-5-one; methyl 5-fluoro-4-methoxy-2,6-dioxohexahydro-5-pyrimidine carboxylate; 5-(naphthalen-1-yl)-1-phenyl-1h-tetrazole; 5-(2-phenylquinolin-4-yl)-1,3,4-oxadiazol-2-ol; n-[2,4,5-trimethyl-4-(trichloromethyl)cyclohexa-2,5-dien-1-ylidene]hydroxylamine; 4-benzoyl-3,4-dihydro-benzo[f]quinoline-3-carbonitrile; 2-nitro-3-phenylspiro[cyclopropane-1,9′-fluorene]; 3-[4-(furan-2-ylmethyl)-5-sulfanylidene-1,2,4-dithiazolidin-3-ylidene]-1,1-dimethyl-thiourea; (6-acetamido-7-methyl-5,8-dioxo-2,3-dihydro-1h-pyrrolo[1,2-a]benzimidazol-3-yl)2-methoxyacetate; 5-iodo-1h-indole-2,3-dione; 4,5-dihydro-1,2,9,10-tetramethoxy dibenzo[de,g]quinoline-6-carboxylic acid, ethyl ester; [2,6-bis(2,4-dimethylphenyl)-4-(2-methoxyacetyl)oxy-phenyl]2-methoxyacetate; 5,11-dimethyl-2-(2-piperidin-1-ylethyl)-6h-pyrido[4,3-b]carbazol-2-ium-9-ol; 2-[3-[[4-[(3-nitroacridin-9-yl)amino]phenyl]sulfamoyl]propyl]guanidine; 1-[[2-(dimethylamino)ethyl]amino]-7-hydroxy-4-methyl-9h-thioxanthen-9-one; 5-amino-1h-1,2,4-triazole-3-carboxylic acid, methyl ester; methyl n-cyano-n′-prop-2-en-1-ylcarbamimidothioate; 5,7-dinitro-8-quinolinol; 5-nitrosoquinolin-8-ol; cantharidin; 1,7-diaminoacridine; 3-methyl-3-(1-naphthyl)-2-benzofuran-1(3h)-one; dichlorolapachol; lycobetaine; 6-(1-aziridinyl)-2,3-dihydro-3-(propionyl)-7-methyl-1h-pyrrolo[1,8]-dione; 4-nitroestrone 3-methyl ether; 5,11-dimethyl-6h-pyrido[4,3-b]carbazole-1-carboxamide hydrochloride; 5-methoxysterigmatocysin; (6-acetamido-7-methyl-5,8-dioxo-2,3-dihydro-1h-pyrrolo[1,2-a]benzimidazol-3-yl)2-methoxyacetate; horminon; 7′,8′-dimethyl-2′-oxo-4′,4a′,6a′,7′-tetrahydro-2′h-spiro[oxirane-2,1′-pentaleno[1,6a-c]pyran]-5′-carboxylate; nybomycin acetate; 5h-[1,6]indeno[1,2-c]isoquinoline-5,12-dione; 2,3-dimethoxy-6-methyl-nitidine; iproplatin; 3-[(deoxyhexosyl)oxy]-2-(3,4-di-hydroxyphenyl)-6,8-dihdroxy-4h-1-benzopyran-4-one; 2-o-benzyl 8-o-methyl 3-(4-methylphenyl)sulfonyl-4,5-dioxo-6h-pyrrolo[3,2-e]indole-2,8-dicarboxylate; 6-bromo-5,8-dihydroxy-7-[4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]naphthalene-1,4-dione; 5-methylbenzo[c]phenanthridin-5-ium-2,3,8,9-tetrol; (6-acetyl-4-oxo-1,3-diphenyl-2-sulfanylidenethieno[2,3-d]pyrimidin-5-yl)-2,4-dichlorobenzoate; n—[c-[4-[bis(2-cyanoethyl)amino]-2-methylphenyl]-n-(4-methylanilino)carbonimidoyl]imino-4-methylbenzamide; gelcohol; curcumin; tirandamycin; noscapine; aristolochic acid; himbacine; fumagillin; fumitremorgin c; physalin b; derivatives, or salt thereof, for use in bone growth processes.
Emory University


05/21/15
20150141652 

Process for preparing 2-[(2e)-2-fluoro-2-(3-piperidinylidene)ethyl]-1h-isoindole-1,3(2h)-dione


The present invention relates to an improved process for preparing 2-[(2e)-2-fluoro-2-(3-piperidinylidene)ethyl]-1h-isoindole-1,3(2h)-dione, or a salt thereof, which is an intermediate in the synthesis route of the antibacterial compound 7-[(3e)-3-(2-amino-1-fluoroethylidene)-1-piperidinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo 3-quinolinecarboxylic acid.. .
Janssen Pharmaceutica Nv


05/21/15
20150141436 

Indoles


Where the various groups are defined herein, and which are useful for treating cancer.. .

05/14/15
20150133674 

Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor


The present application is directed to processes and intermediates for making 4-({2-[(aminosulfonyl)amino]ethyl}amino)-n-(3-bromo-4-fluorophenyl)-n′-hydroxy-1,2,5-oxadiazole-3-carboximidamide, which is an inhibitor of indoleamine 2,3-dioxygenase, useful in the treatment of cancer and other disorders.. .

05/14/15
20150133660 

Method for producing n-sulfonyl-substituted oxindoles


Process for the selective n-sulfonylation of oxindoles, in particular process for the n-sulfonylation of 3-triazinyloxindoles, and also n-sulfonyl-substituted 3-triazinyl-oxindoles and the use of n-sulfonyl-substituted oxindoles and of n-sulfonyl-substituted 3-triazinyloxindoles as intermediates for the synthesis of fine chemicals and of active ingredients in the field of pharmacy and agriculture, and also the use of these compounds as active ingredients in the field of agriculture.. .

05/14/15
20150133654 

Novel methods and intermediates for the preparation of (4bs,5ar)-12-cyclohexyl-n-(n,n-dimethylsulfamoyl)-3-methoxy-5a-((1r,5s)-3-methyl-3,8-diazabicyclo[3.2.1]octane-8-carbonyl)-4b,5,5a,6-tetrahydrobenzo [3,4]cyclopropa[5,6]azepino[1,2-a]indole-9-carboxamide


The present invention provides methods and intermediates for the preparation of (1ar,12bs)-8-cyclohexyl-11-fluoro-n-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,12b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide (formula i), including pharmaceutically acceptable salts. The compound has activity against hepatitis c virus (hcv) and may be useful in treating those infected with hcv..

05/14/15
20150133411 

Compounds with trpv4 activity, compositions and associated methods thereof


Compounds, compositions and methods useful for treating ocular diseases are provided. In particular, antagonists of trpv4, their synthesis, pharmaceutical compositions thereof and methods of treating ocular diseases such as glaucoma, are disclosed.

05/14/15
20150132513 

Indoline-nitroxide radical as stabiliser and inhibitor for reaction resins, reaction resins containing same and use thereof


Use of a stable indole-nitroxide radical as a stabilizer and/or inhibitor for resin mixtures and reactive resin mortars is described on the basis of radically curable compounds. Resin mixtures and reactive resin mortars may be made stable in storage very effectively using the indole nitroxide radical and the pot life of mortar compositions can be adjusted in a targeted manner..

05/07/15
20150127593 

Platform to acquire and represent human behavior and physical traits to achieve digital eternity


An artificial intelligence platform that is capable of reproducing a person's identity and allowing others to interact with it is described. It does so by creating a digital identity, founded on the very concept of a digital soul capable of bringing back to life (mirroring) the physical aspect, behavior, emotions, mannerisms and relational sphere of the subject.
Forever Identity, Inc.


05/07/15
20150126737 

Method for producing triazinyl-substituted oxindoles


And salts thereof by reacting an oxindole (1) with a triazine (2) in the presence of a carbonate, a hydroxide, a phosphate or a mixture of two or more of the aforementioned compounds, and also the compounds of formula (3) and salts thereof (3″) and the use of both for producing crop protection agents.. .

05/07/15
20150125548 

Combination nutritional and nutraceutical products


The present invention is directed to nutritional and nutraceutical compositions which comprise novel mixtures of two or more indole-based dietary supplements such as l-tryptophan and melatonin, together with selected minerals and vitamins that stimulate tryptophan metabolism in the direction of serotonin and melatonin, and to their use in a preferred embodiment of the invention in a readily ingested beverage form, optionally combined with a range of other natural ingredients designed to improve the health and state of mind of human subjects. Alternative dosage forms, such as tablets for oral dosing, and dosage forms for buccal and sublingual administration, including thin films, are also incorporated in the present invention.
Requis Pharmaceuticals Inc.


04/30/15
20150119394 

Insulin-like growth factor-1 receptor inhibitors


The present invention relates to compounds that are capable of inhibiting, modulating and/or regulating insulin-like-growth factor i receptor and insulin receptor. The compounds of the instant invention possess a core structure that comprises a sulfonyl indole moiety.
Piramal Enterprises Limited


04/23/15
20150111942 

Ipa as a therapeutic agent, as a protective agent, and as a biomarker of disease risk


indole-3-propionic acid as a marker and for treatment for huntington disease.. .
Counterpoint Health Solutions, Inc.


04/09/15
20150099884 

Processes and intermediates for producing azaindoles


The present invention relates to processes and intermediates for the preparation of compounds useful as inhibitors of janus kinases (jak).. .
Vertex Pharmaceuticals Incorporated


04/02/15
20150094328 

4-azaindole derivatives


4-azaindole derivatives which are modulators of muscarinic acetylcholine receptor (machr) m1 and which may be effective for the prevention or disease modifying or symptomatic treatment of cognitive deficits associated with neurological disorders such as alzheimer-type dementia (ad) or dementia with lewy bodies (dlb), and a pharmaceutical composition comprising a 4-azaindole derivative as an active ingredient.. .
Eisai R&d Management Co., Ltd.


03/26/15
20150087652 

Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitors


This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives.
Bristol-myers Squibb Company


03/26/15
20150087617 

Indole, indoline derivatives, compositions comprising them and uses thereof


The invention provides indole and indoline derivatives and slats thereof, compositions comprising them and uses thereof for the treatment of diseases and disorders.. .
Bar Ilan University


03/19/15
20150080316 

Functionalized thieno-indole derivatives for the treatment of cancer


The invention relates to new functionalized thieno-indole derivatives of formula (i) or (ii) which have cytotoxic activity and are useful in treating diseases such as cancer and cellular proliferation disorders. The invention also relates to the use of these functionalized thieno-indole derivatives in the preparation of conjugates.
Nerviano Medical Sciences S.r.l.


03/12/15
20150073013 

Indoles as respiratory syncytial virus antiviral agents


The prodrugs, n-oxides, addition salts, quaternary amines, metal complexes and stereochemically isomeric forms thereof; compositions containing these compounds as active ingredient and processes for preparing these compounds and compositions.. .

03/05/15
20150065537 

Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists


The invention relates to novel benzothiophene-, benzofuran-, and indole ureas and to the use thereof for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning, and/or memory.. .
Bayer Intellectual Property Gmbh


03/05/15
20150065535 

Method of restoring the incretin effect


The present invention relates to methods of treating metabolic syndrome type 2 diabetes mellitus atherogenic dyslipidemia and/or obesity. The present invention also relates to methods of restoring the incretin effect, to restoring physiologic control of glucagon levels, to restoring first-phase insulin secretion, and to restoring the physiologic glucose-dependent insulin secretion.
Neurendo Pharma, Llc


03/05/15
20150065466 

Novel dxr inhibitors for antimicrobial therapy


The present invention generally concerns particular methods and compositions for antimicrobial therapy. In particular embodiments, the compositions target dxr.
Baylor College Of Medicine


02/26/15
20150057326 

Method for synthesizing cycloalkanyl[b]indoles, cycloalkanyl[b]benzofurans, cycloalkanyl[b]benzothiophenes, compounds and methods of use


A method of synthesizing cycloalkanyl[b]indoles, as well as related cycloalkanyl[b]benzofurans and cycloalkanyl[b]benzothiophenes is provided. The method is a single, multicomponent reaction that combines (1) an indole, benzofuran, or benzothiopene, (2) an aldehyde, ketone, or ketal, and (3) a diene in the presence of an acid, in particular a ga(iii) or in(iii) salt.
Trustees Of Dartmouth College


02/19/15
20150051218 

Pyrido[4,3-b]indoles containing rigid moieties


This disclosure is directed to pyrido[4,3-b]indoles having rigid moieties. The compounds in one embodiment are pyrido[4,3-b]indoles having an unsaturated hydrocarbon moiety.
Medivation Technologies, Inc.


02/19/15
20150051154 

Alkylating agents


The present invention relates to a novel class of alkylating agents comprising a thieno-indole moiety linked to a dna-binding moiety, which have cytotoxic activity and are useful in treating diseases such as cancer, cellular proliferation disorders and viral infections. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising them and methods of treating diseases utilizing such compounds or the pharmaceutical composition containing them.
Nerviano Medical Sciences S.r.l.


02/12/15
20150044876 

Resist underlayer film forming composition containing phenylindole-containing novolac resin


Preferably, both rings a and b are benzene rings, n1, n2, and n3 are 0, r4 and r6 are hydrogen atoms, or r5 is naphthyl. A method for producing a semiconductor device including: forming an underlayer film by use of the resist underlayer film forming composition onto a semiconductor substrate; forming a hard mask on the underlayer film; forming a resist film on the hard mask; forming a resist pattern by irradiation with light or an electron beam and development; etching the hard mask using the resist pattern; etching the underlayer film by use of the patterned hard mask; and processing the semiconductor substrate by use of the patterned underlayer film..

02/12/15
20150044735 

Biosynthetic systems producing fungal indole alkaloids


The biosynthesis of fungal bicyclo[2.2.2]diazaoctane indole alkaloids with a wide spectrum of biological activities have attracted increasing interest. Their intriguing mode of assembly has long been proposed to feature a non-ribosomal peptide synthetase, a presumed intramolecular diels-alderase, a variant number of prenyltransferases, and a series of oxidases responsible for the diverse tailoring modifications of their cyclodipeptide-based structural core.
Colorado State Universtiy


02/12/15
20150044705 

Protein detection using modified cyclodextrins


A method is provided for detecting a protein using a cyclodextrin covalently linked to at least one label. The cyclodextrin can associate with the protein by sequestering an aromatic amino acid side-chain of the protein in its hydrophobic cavity.
Bio-rad Laboratories, Inc.


02/05/15
20150038544 

Animal feed composition


Disclosed is an animal feed composition that comprises free indole acetic acid (free iaa) or a derivative thereof. Also disclosed is a method for enhancing animal growth by feeding the animal with a composition according to the invention.
Veijlen N.v.


02/05/15
20150038543 

Anti-glycation properties of oxindole derivatives


This invention provides a series of new oxindole derivatives 1-21, evaluated for their antiglycation potential by using in vitro bsa-mg glycation model. These derivatives showed a varying degree of antiglycation activity with ic50 values ranging between 150-856 μm.

02/05/15
20150038526 

Fluorine-containing 5-[2-(pyrid-3-yl)-ethyl]-2,3,4-tetrahydro-1h-pyrido[4,3-b]indoles as agents for reducing uncontrolled protein aggregation


R9═f, 2f, chf2, cclf2, cf3.; x=nothing, cl. Br..

02/05/15
20150038517 

Indole derivative modulators of the alpha 7 nachr


Wherein r1 is imidazolyl, pyridinyl or pyrimidinyl, any of which is optionally substituted by one group independently selected from c1-3alkyl and c1-3alkoxy.. .

02/05/15
20150038484 

Indole and indazole compounds that activate ampk


That activate 5′ adenosine monophosphate-activated protein kinase (ampk). The invention also encompasses pharmaceutical compositions containing these compounds and methods for treating or preventing diseases, conditions, or disorders ameliorated by activation of ampk..



Popular terms: [SEARCH]

Indole topics: Indole Derivatives, Tryptophan, Pharmaceutically Acceptable Salt, Protease Inhibitors, Antivirals, Antiinfective, Pharmaceutical Formulations, Protease Inhibitor, Pharmaceutical Formulation, Immunomodulator, Entry Inhibitors, Piperazine, Cycloalkyl, Alkyl Group, Carbon Atoms

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Indole for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Indole with additional patents listed. Browse our RSS directory or Search for other possible listings.


0.7357

4455

72 - 0 - 102